PFE dividend yield: 6.77%. ORCL dividend yield: 4.00%. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity. ORCL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ORCL shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
ORCL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ORCL shares.
Is PFE or ORCL better for dividend income in 2026?
PFE currently offers a 6.77% yield (1.68/share/year) while ORCL offers 4.00% (2.00/share/year). PFE provides higher current income. However, ORCL has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in PFE vs ORCL earn per year?
With $10,000 invested today: PFE pays approximately $677/year. ORCL pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $5,820/year (PFE) and $899/year (ORCL).
Does PFE or ORCL pay monthly dividends?
PFE pays quarterly dividends. ORCL pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this PFE vs ORCL comparison by email
Save your analysis + get weekly dividend insights. Free forever.